Showing results (631-640 of 777) with videos related to

Sort By:
Pageof 78
American Journal of Respiratory Cell and Molecular Biology|January 26, 2013
Macrophage A2A adenosinergic receptor modulates oxygen-induced augmentation of murine lung injuryNeil R Aggarwal, Franco R D'Alessio, Yoshiki Eto, et al.
Circulation|October 26, 2018
Heart Centers for Women: Historical Perspective on Formation and Future Strategies to Reduce Cardiovascular DiseaseGina P Lundberg, Laxmi S Mehta, Rupa M Sanghani, et al.
Mucosal Immunology|May 23, 2014
Foxp3+ regulatory T cells promote lung epithelial proliferationJ R Mock, B T Garibaldi, N R Aggarwal, et al.
JACC. Advances|June 28, 2024
Recommendations for the Management of High-Risk Cardiac Delivery: ACC Cardiovascular Disease in Women Committee PanelEmily S Lau, Niti R Aggarwal, Joan E Briller, et al.
Cancer Research Communications|November 13, 2025
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)Andre L De Souza, Matthew J Hadfield, Shaolei Lu, et al.
Open Heart|July 5, 2017
Higher number of live births is associated with left ventricular diastolic dysfunction and adverse cardiac remodelling among US Hispanic/Latina women: results from the Echocardiographic Study of LatinosShivani R Aggarwal, David M Herrington, Catherine J Vladutiu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 studyA R Hansen, C Massard, P A Ott, et al.
BMC Cancer|March 6, 2019
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancerJanice M Mehnert, Andrea Varga, Marcia S Brose, et al.
JAMA Health Forum|September 13, 2024
A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal AntibodiesMengli Xiao, Kyle C Molina, Neil R Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate CancerRahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
Pageof 78